Feb 22, 2012 / 02:24 am
A new survey reveals that pharmacy directors across the country do not believe that a mandate requiring insurance companies to offer free contraceptives will cut costs as the Obama administration has predicted.
“It was interesting that no one thought the mandate would offset costs by preventing unintended pregnancies,” said Rhonda Greenapple, CEO of the firm that conducted the survey. “This is in direct opposition to the rationale for mandating these services.”
The survey, announced Feb. 17, was administered by Reimbursement Intelligence, a market research firm specializing in reimbursement issues for medical and pharmaceutical companies.
Fifteen pharmacy directors, “representing tens of millions of pharmacy-covered lives,” were asked about what impact they think the Obama administration’s new contraception mandate will have on their plans.